These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2424079)

  • 1. Does liver-intestine significantly degrade circulating endogenous substance P in man?
    Henriksen JH; Schaffalitzky de Muckadell OB; Bülow JB
    Scand J Gastroenterol; 1986 Apr; 21(3):300-4. PubMed ID: 2424079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intestine as source of immunoreactive substance P in plasma of the cat.
    Gamse R; Mroz E; Leeman S; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):17-21. PubMed ID: 723966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating hyaluronate: concentration in different vascular beds in man.
    Bentsen KD; Henriksen JH; Laurent TC
    Clin Sci (Lond); 1986 Aug; 71(2):161-5. PubMed ID: 3720193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man.
    Henriksen JH; Tronier B; Bülow JB
    Metabolism; 1987 May; 36(5):463-8. PubMed ID: 3553849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of endogenous gastrin in man.
    Petersen B; Henriksen JH; Rehfeld JF; Christiansen J
    Scand J Gastroenterol; 1981; 16(6):727-30. PubMed ID: 7323706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous pancreatic polypeptide in different vascular beds: relationship to release and degradation in subjects with normal and decreased kidney function.
    Henriksen JH; Schwartz TW; Bülow JB
    Metabolism; 1986 Jun; 35(6):542-6. PubMed ID: 3713514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
    Koch TR; Carney JA; Go VL
    Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
    Emson PC; Gilbert RF; Martensson H; Nobin A
    Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin.
    Henriksen JH; Holst JJ; Moller S; Andersen UB; Bendtsen F; Jensen G
    Clin Sci (Lond); 2000 Dec; 99(6):527-34. PubMed ID: 11099396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P, vasoactive intestinal polypeptide, and gastrin catabolism in canine liver and kidney.
    Kabemura T; Misawa T; Chijiiwa Y; Nasu T; Nawata H
    Dig Dis Sci; 1992 Nov; 37(11):1661-5. PubMed ID: 1385057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic inactivation of substance P in the epithelial layer of the intestine.
    Nau R; Schäfer G; Conlon JM
    Biochem Pharmacol; 1985 Nov; 34(22):4019-23. PubMed ID: 2415132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the release of endogenous substance P from intestinal nerves.
    Franco R; Costa M; Furness JB
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):195-201. PubMed ID: 224322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine.
    Korman LY; Sayadi H; Bass B; Moody TW; Harmon JW
    Dig Dis Sci; 1989 Jul; 34(7):1100-8. PubMed ID: 2472937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution and colocalization of neuropeptides in perivascular nerves innervating the large arteries and veins of the snake, Elaphe obsoleta.
    Davies PJ; Donald JA
    Cell Tissue Res; 1992 Sep; 269(3):495-504. PubMed ID: 1384980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
    Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
    Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P is markedly increased in plasma of patients with hepatic coma.
    Hörtnagl H; Singer EA; Lenz K; Kleinberger G; Lochs H
    Lancet; 1984 Mar; 1(8375):480-3. PubMed ID: 6199630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
    Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
    Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.